저용량 브로모크립틴 치료로 반복적인 정상 임신과 종양 감퇴를 보인 거대프로락틴선종 1예 = Normal Repetitive Pregnancies and Tumor Regression Induced by Low-Dose Bromocriptine in a Patient with Macroprolactinoma

다국어 초록 (Multilingual Abstract)

Prolactin-secreting adenomas are the most common pituitary tumors. Menstrual disturbances and infertility are the main complaints in women with prolactinoma. Dopaminergic agonists such as bromocriptine are well-established treatments for prolactinoma when pregnancy is desired. Pregnancy-related outcomes in macroprolactinoma are worse than those in microprolactinoma. In addition, symptomatic tumor expansion during pregnancy occurs in 30% of women with macroprolactinoma. Therefore, when women with macroprolactinoma are planning a pregnancy, serum prolactin level should be normalized and the tumor volume significantly reduced. On the other hand, a spontaneous regression of macroprolactinoma can occur after pregnancy. We report a case of macroprolactinoma showing significant tumor regression during repeated pregnancies and low dose bromocriptine treatment, with a literature review.

참고문헌 (Reference)

1 Holmgren U, "Women with prolactinoma - effect of pregnancy and lactation on serum prolactin and on tumour growth" 111 : 452-458, 1986

2 Hardy J, "Transsphenoidal microsurgical removal of pituitary micro-adenoma" 6 : 200-216, 1975

3 Trukalj I, "Surveillance of bromocriptine in pregnancy" 247 : 1589-1591, 1982

4 Crosignani PG, "Spontaneous and induced pregnancies in hyperprolactinemic women" 58 : 708-713, 1981

5 Serri O, "Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma" 309 : 280-283, 1983

6 Bronstein MD, "Prolactinomas and pregnancy" 8 : 31-38, 2005

7 Monroe SE, "Prolactin secreting pituitary adenomas: V. Increased gonadotropin responsivity in hyperprolactinemic women with pituitary adenomas" 52 : 1171-, 1981

8 Hardy J, "Prolactin secreting pituitary adenomas : transsphenoidal microsurgical treatment. Progress in Prolactin Physiology and Pathology" Elesvier-North Holland Biomedical Press 361-, 1978

9 Magyar DM, "Pituitary tumor and pregnancy" 132 : 739-, 1978

10 Molitch ME, "Pituitary incidentalomas" 26 : 725-740, 1997

11 Gemzell C, "Outcome of pregnancy in women with pituitary adenoma" 31 : 363-, 1979

12 Bronstein MD, "Medical management of pituitary adenomas: the special case of management of the pregnant woman" 5 : 99-107, 2002

13 Molitch ME, "Management of prolactinomas during pregnancy" 44 : 1121-1126, 1999

14 Ahmed M, "Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies" 58 : 492-497, 1992

15 Liuzzi A, "Low doses of dopamine agonists in the long-term treatment of macroprolactinomas" 313 : 656-659, 1985

16 Essaïs O, "Efficacy and safety of bromocriptine in the treatment of macroprolactinomas" 63 : 524-531, 2002

17 Spark RF, "Bromocriptine reduces pituitary tumor size and hypersecretion" 247 : 311-, 1982

18 Cuellar FG, "Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia" 55 : 278-, 1980

19 Molitch ME, "Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study" 60 : 698-705, 1985

20 Mindermann T, "Age-related and gender -related occurrence of pituitary adenomas" 41 : 359-364, 1994